These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24912526)

  • 1. Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy.
    Avci A; Alizade E; Fidan S; Yesin M; Guler Y; Kargin R; Esen AM
    Scand Cardiovasc J; 2014 Aug; 48(4):202-8. PubMed ID: 24912526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and risk profile in adolescents with idiopathic dilated cardiomyopathy.
    Limongelli G; Pacileo G; Ancona R; Eusebio G; D'Andrea A; Romano M; Di Salvo G; Rea A; Calabró P; Romano G; Maiello C; Calabró R
    Am J Cardiol; 2010 Mar; 105(5):716-20. PubMed ID: 20185022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of clinical, electrocardiographic, echocardiographic and neurohumoral parameters in non-ischaemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Tanalp AC; Gurel E; Cevik C; Mutlu B; Basaran Y
    Acta Cardiol; 2008 Apr; 63(2):207-12. PubMed ID: 18468202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.
    Fujimoto N; Onishi K; Sato A; Terasaki F; Tsukada B; Nozato T; Yamada T; Imanaka-Yoshida K; Yoshida T; Ito M; Hiroe M
    J Card Fail; 2009 Dec; 15(10):898-905. PubMed ID: 19944367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of epicardial fat thickness to the severity of heart failure in patients with nonischemic dilated cardiomyopathy.
    Tabakci MM; Durmuş Hİ; Avci A; Toprak C; Demir S; Arslantaş U; Cerşit S; Fidan S; Kulahçioğlu Ş; Batgerel U; Kargin R
    Echocardiography; 2015 May; 32(5):740-8. PubMed ID: 25418427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?
    Heringer-Walther S; Moreira Mda C; Wessel N; Wang Y; Ventura TM; Schultheiss HP; Walther T
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):293-8. PubMed ID: 17204908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of cardiopulmonary exercise test in cardiac function evaluation of patients with chronic left heart failure caused by dilated cardiomyopathy].
    Zhang W; Huang J; Xu H; Zhang S; Liu Z; Liao Z; Ma X; Liu Q
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1076-9. PubMed ID: 24851891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure biomarkers in patients with dilated cardiomyopathy.
    Bielecka-Dabrowa A; von Haehling S; Aronow WS; Ahmed MI; Rysz J; Banach M
    Int J Cardiol; 2013 Oct; 168(3):2404-10. PubMed ID: 23416015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Choi BR; Kim JS; Yang YJ; Park KM; Lee CW; Kim YH; Hong MK; Song JK; Park SW; Park SJ; Kim JJ
    Am J Cardiol; 2006 May; 97(9):1365-9. PubMed ID: 16635612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extremely high brain natriuretic peptide does not reflect the severity of heart failure.
    Law C; Glover C; Benson K; Guglin M
    Congest Heart Fail; 2010; 16(5):221-5. PubMed ID: 20887619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Fukunaga T; Soejima H; Irie A; Sugamura K; Oe Y; Tanaka T; Nagayoshi Y; Kaikita K; Sugiyama S; Yoshimura M; Nishimura Y; Ogawa H
    Am J Cardiol; 2007 Aug; 100(3):483-8. PubMed ID: 17659933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.